Concepedia

Publication | Closed Access

Phase I study of icotinib hydrochloride (BPI-2009H), an oral EGFR tyrosine kinase inhibitor, in patients with advanced NSCLC and other solid tumors

DOI

97

Citations

25

References

2010

Year

Qiong Zhao, Jianzhong Shentu, Nong Xu, Jianya Zhou, Guangdie Yang, Yinan Yao, Fenlai Tan, Dongyang Liu, Yingxiang Wang, Jianying Zhou
Lung Cancer

References

YearCitations

Page 1